Researchers from one of Sri Lanka's leading universities, the Sri Jayewardenepura University, have found that China's Sinopharm COVID-19 vaccine is highly efficient against the Delta variant which has become the dominant variant across the world. According to the study, 95 percent of individuals who received two doses of the Sinopharm vaccine have developed antibodies similar to a naturally infected COVID-19 person.